In 2009 the FDA's unit that regulates advertising has sent 41 enforcement letters to crack down on questionable marketing claims, twice the number sent in 2008.
For example, When drug maker Allergan came out with the new eyelash thickening drug Latisse last year, it put on a marketing blitz featuring actress Brooke Shields. The Latisse Web site showed her longer, thicker lashes from the drug.
However, the site barely mentioned Latisse's side effects, which can include hair growth outside of the treatment area, a permanent darkening of eye color and bacterial infections that can lead to blindness.
In response the FDA issued an official warning letter in September 2009 and scolded
Allergan for its "misleading" claims about Latisse, which it said "omit and minimize" the drug's side effects. It demanded the company fix the web site immediately.
This and other 10 misleading ads published by Forbes.
Gilad Karni
Posts
No comments:
Post a Comment